OBJECTIVE
To evaluate the safety and efficacy of 2 dosages of cevimeline for the treatment of xerostomia and keratoconjunctivitis sicca in patients with Sjögren's syndrome.
METHODS
A 12-week double-blind, randomized, placebo-controlled study was performed. Patients were randomly assigned to receive